enParticle: Biotech platform for a microfluidic CDMO
Client: enParticle Year: 2023 Services: Web Design & Development, Bilingual Content Architecture, Brand Systems Duration: Roughly 8-10 weeks Tech: WordPress, Elementor, WPML
The problem
enParticle is a microfluidic drug-delivery CDMO based in Korea. They make the enCell family of devices (Master, Pharm, Scale-Up) for mRNA vaccine production, lipid nanoparticle formulation, and other drug-delivery-system work. The buyer is a pharma R&D director or a CDMO procurement lead, and that buyer is reading the site the same week they are reading sites from dozens of other vendors in the same space.
The previous site read like a Korean industrial-equipment brochure. It was competent, but the category expected something else: biotech sites in pharma CDMO look contemporary, cite the science directly, and carry investor-grade polish alongside the product story. enParticle wanted a bilingual build (EN primary, KO secondary) that would read credibly to a Pfizer or Moderna partnerships lead scanning vendors, and still work for a Korean regulatory filing.
Career and investor sections were part of the scope. enParticle was hiring and raising in parallel with the launch.
What we built
A bilingual pharma-CDMO platform that leads with the enCell product family and pulls the science to the surface.
- Three-tier enCell product page: Master (research scale), Pharm (clinical, 100 mL/min), Scale-Up (high-volume production for pharma and cosmetics)
- mRNA / LNP / DDS positioning pulled into the hero copy rather than buried in technical spec pages
- Investor section with news, filings, and press-release archive
- Career section with open roles and a direct application path
- News and blog module with social integration (LinkedIn, Facebook, Twitter, YouTube, Instagram)
- Korean and English builds via WPML, both treated as primary rather than one being a translation afterthought
- Consultation and partnership-inquiry forms routed to the right internal inbox by origin page
How we built it
Weeks 1-2. Content and scientific-accuracy review. Biotech sites die on imprecise language. We worked with enParticle's R&D lead to get the enCell descriptions to a level where a pharma R&D director would not roll their eyes.
Weeks 3-4. Product-family information architecture. Master, Pharm, Scale-Up needed to read as a progression, not three separate products. We designed the page system so a visitor lands on one and naturally moves to the next.
Weeks 5-6. Elementor build, investor and career section, news module integration. Contemporary biotech visual system: white space, pale accents, scientific imagery, no industrial-brochure tropes.
Weeks 7-8. Korean build through WPML. Native-speaker review on the science terminology in Korean (terminology drift between English pharma and Korean pharma is real and costly if you get it wrong).
Weeks 9-10. Investor-section integration, social-feed aggregation, QA, launch.
What it changed
enParticle's partnership inbox started receiving inquiries that quoted the product copy back at them. That is the signal a CDMO site is working: the other side of the conversation uses your language. Before the rebuild the inquiries were generic; after, they mentioned enCell Pharm by name and referenced the flow rate.
What we learned
Biotech visual conventions differ from industrial visual conventions. White space, typography, and imagery choices that work for a Korean heavy-industry client read as cheap for a CDMO. The two verticals share a country and share very little else. Build the design system to the buyer, not to the client's other Korean peers.
Investor content lives adjacent to product content, not in a separate section. The first draft put investor pages behind a gated sub-nav. Nobody used it. Moving investor updates into the main news feed (with an "investor" tag filter) increased visibility for the pages that actually matter during a raise.
Product families need hierarchy, not parity. Master, Pharm, Scale-Up are the same device at different production scales. The first IA presented them as equal siblings. The real buyer journey moves up the scale, and the site worked better when it reflected that journey visually.
Stack
- WordPress
- Elementor
- WPML for EN/KO delivery
- Social-feed aggregation (LinkedIn, Instagram, YouTube)
- News / investor module with tag filtering
- Custom partnership-inquiry routing
Want something similar?
Biotech, CDMO, medical-device, pharma-adjacent brands that need the site to read contemporary rather than industrial. The web design and development service page covers how we scope these. Email hello@cclemang.com if you have a product family that needs a proper hierarchy.
